نتایج جستجو برای: anticoagulant therapy

تعداد نتایج: 662204  

2016
Kazuma Yamakawa Yutaka Umemura Mineji Hayakawa Daisuke Kudo Masamitsu Sanui Hiroki Takahashi Yoshiaki Yoshikawa Toshimitsu Hamasaki Satoshi Fujimi

BACKGROUND Little evidence supports anticoagulant therapy as effective adjuvant therapy to reduce mortality overall in sepsis. However, several studies suggest that anticoagulant therapy may reduce mortality in specific patients. This study aimed to identify a subset of patients with high benefit profiles for anticoagulant therapy against sepsis. METHODS This post hoc subgroup analysis of a n...

2011
Walter Ageno Mark Crowther Elaine M. Hylek

on laboratory and clinical monitoring and on reversal strategies. More recently, new oral anticoagulant drugs, namely the direct thrombin inhibitor dabigatran etexilate and the direct factor Xa inhibitor rivaroxaban, have been approved for clinical use in several countries. A growing body of laboratory and clinical data is becoming available to better understand the mechanisms of action and the...

Journal: :iranian journal of neonatology 0
reza saeidi department of pediatrics, associate professor of neonatology, mashhad university of medical sciences,mashhad, iran reza gharaee department of pediatrics, fellow of neonatology, mashhad university of medical sciences , mashhad, iran zohreh nobakht rheumatologist, mashhad university of medical sciences , mashhad, iran

neonatal purpura fulminans is a rare and life threatening disease that can be inherited or acquired in etiology. it manifests as dic and extensive subcutaneous thrombosis. the condition is often fatal unless there is prompt diagnosis, and judicious therapy. the most important causes of this condition are infections and congenital deficiency of anticoagulant proteins c and s.in the case of pc (p...

Journal: :Circulation 2009
John W Eikelboom Jeffrey I Weitz

Adjunctive anticoagulant therapy reduces the risk of recurrent infarction and death in patients with STsegment elevation myocardial infarction (STEMI) receiving fibrinolytic therapy.1–5 Unfractionated heparin (UFH), the first anticoagulant evaluated for this indication,1 continues to be used because of its predominantly nonrenal clearance, short half-life, reversibility, and the familiarity of ...

Journal: :Mayo Clinic Proceedings 1995

Journal: :Journal of the American College of Cardiology 1991

Journal: :Seminars in Thrombosis and Hemostasis 2015

Journal: :Nature Reviews Nephrology 2013

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید